Other genetic variations having also been linked with NAFLD, including, but not limited to, transmembrane 6 superfamily member 2 (TM6SF2), membrane-bound O-acyltransferase domain-containing 7 (MBOAT7), and glucokinase regulator (GCKR) genes [21]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.